Human YAP1/COB1/YAP ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_001130145.3)
Cat. No.: pGMAAV000884
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human YAP1/COB1/YAP Adeno-associated virus expression plasmid (ITR-vector) for YAP1 AAV packaging, YAP1 AAV production.The purified Human YAP1/COB1/YAP AAV particle serves as an invaluable asset for in-depth in vivo YAP1 studies, mechanism of action (MOA) research, and the evolution of YAP1-associated gene therapy strategies.
Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.
Go to
YAP1/COB1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMAAV000884 |
Gene Name | YAP1 |
Accession Number | NM_001130145.3 |
Gene ID | 10413 |
Species | Human |
Product Type | Adeno-associate virus(AAV) plasmid (overexpression) |
Insert Length | 1515 bp |
Gene Alias | COB1,YAP,YAP2,YAP65,YKI |
Fluorescent Reporter | Null |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | TIE |
Resistance | Amplicin |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
Target ID | GM-T94048 |
Target Name | YAP1 |
Gene ID | 10413, 22601, 704382, 363014, 101101408, 479465, 100336629, 100068834 |
Gene Symbol and Synonyms | COB1,YAP,YAP-1,YAP-65,YAP1,YAP2,YAP65,YKI,Yorkie |
Uniprot Accession | P46937 |
Uniprot Entry Name | YAP1_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | Cancer |
Gene Ensembl | ENSG00000137693 |
Target Classification | Tumor-associated antigen (TAA) |
This gene encodes a downstream nuclear effector of the Hippo signaling pathway which is involved in development, growth, repair, and homeostasis. This gene is known to play a role in the development and progression of multiple cancers as a transcriptional regulator of this signaling pathway and may function as a potential target for cancer treatment. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2013]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.